E-mail a Wiley Online Library Link

Nadia Warner and Stephen Locarnini The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound Hepatology 48

Version of Record online: 21 FEB 2008 | DOI: 10.1002/hep.22295

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field